AP-102

Star0

DB18206ExperimentalSmall molecule

AP-102: Overview.

Mechanism: Pharmacologically active on Somatostatin receptor type 5 and Somatostatin receptor type 2
Curator reviewed
Formula / weight: C₅₀H₆₆I₂N₁₂O₁₀S₂ · 1313.08 g/mol (avg)
Also known as: H-(4-amino-3-iodo)-d-phe-c(cys-(3-iodo)-tyr-d-trp-lys-val-cys)-thr-nh2 · H-(4-amino-3-iodo)-D-Phe-c[Cys-(3-iodo)-Tyr-D-Trp-Lys-Val-Cys]-Thr-NH2 · L-threoninamide, 4-amino-3-iodo-d-phenylalanyl-l-cysteinyl-3-iodo-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-, cyclic (2->7)-disulfide
Code names: AP-102

Resolves to

Compound

UNIIEW91FWW4HCCAS846569-60-6

Structure

InChIKeyISZMJWBQCGWNNM-FJOHFWBCSA-NSMILES

CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC2=CC=C(O)C(I)=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)NC(=O)[C@H](N)CC1=CC=C(N)C(I)=C1

Targets

P35346SSTR5P30874SSTR2

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with AP-102, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account